BioAsia 2026

Agenda

BioAsia 2026, the premier life sciences & Health-tech event hosted by the Telangana government, will once again unite global leaders across the Life Sciences sector under the theme "TechBio Unleashed: AI, Automation & the Biology Revolution" The theme reflects India’s growing prominence as a global hub for TechBio innovation, where technology and biology converge to shape the future of healthcare. It underscores our commitment to fostering transformative innovations, nurturing cross-border collaborations, and accelerating the adoption of next-generation technologies that are redefining healthcare delivery worldwide.

In an era defined by the convergence of technology and biology, BioAsia 2026 will spotlight the transformative potential of TechBio in reshaping global healthcare. The event will explore critical domains such as synthetic biology, genomics, biomanufacturing, AI-driven drug discovery, and digital health, areas that are driving breakthroughs, revolutionizing treatment pathways, and making healthcare more predictive, precise, and inclusive.

This edition of BioAsia will also highlight India’s emergence as a global TechBio powerhouse and its pivotal role in steering innovations that address some of the world’s most pressing health challenges. By uniting scientists, entrepreneurs, investors, and policymakers, BioAsia 2026 will serve as a powerful platform to accelerate the TechBio revolution and unlock new opportunities at the intersection of science, technology, and healthcare

Our discussions, innovations, and collaborations at BioAsia 2026 under the theme "TechBio Unleashed: AI, Automation & the Biology Revolution" will drive the next era of healthcare transformation, expand the horizons of global health, and cement India’s position as a leading force shaping the future of life sciences.

Day 1
17th February 2026
09:30 - 10:00
Inauguration of International Exhibition
10:00 - 11:00
Inaugural Ceremony • Sri. A. Revanth Reddy, Hon’ble Chief Minister of Telangana
• Sri. D. Sridhar Babu, Hon’ble Minister for Industries and Commerce, Government of Telangana
• Sri. Sanjay Kumar (IAS), Special Chief Secretary, Industries & Commerce, Government of Telangana
11:00 - 11:20
Keynote Address
11:20 - 11:40
Keynote Address Dr. Howard Y. Chang, Chief Scientific Officer and SVP Global Research, Amgen, USA
11:45 - 12:45
Session Sponsor: EY Panel Discussion
Catalysts that Actually Scale: Science, Software & Supply Not every breakthrough changes the world. This discussion explores what it really takes to scale - blending cutting-edge science, digital technologies, and resilient supply chains to move innovation from lab bench to bedside.

Speakers:
• Mr. Eamonn Warren, Group VP, Manufacturing (API & Dry Products), Lilly Global, USA
• Dr. Despina Solomonidou, EVP, Global Head Technical Research & Development, Novartis, Switzerland
• Ms. Rashmi Kumar, SVP & Chief Information Officer, Medtronic, USA
• Dr. Peter Owotoki, Cofounder & CEO, EmpathicAI.life Ltd, Germany
• Prof. Kil To Chong, Founder & CEO, JuYoungBio Corporation, South Korea
• Dr. Kenneth Barr, SVP, Head of Strategic Collaborations, Head of SynVent, Syngene

Moderator: Mr. Daniel Mathews, EY Global and EMEIA Life Sciences Sector Lead, UK
12:45 - 14:00
Networking Lunch & Visit to Exhibition
14:00 - 15:00
Session Sponsor: EY Panel Discussion
From Headwinds to Health Wins: Where Growth Will Come From (’26–’30) Pharma and biotech CEOs dissect growth headwinds - pricing pressure, regulatory shifts, talent shortages - and reveal the growth engines they’re betting on for the next five years.

Speakers:
• Dr. Peter Piot
• Dr. Krishna Prasad Chigurupati, Chairman & MD, Granules
• Mr. Vikrant Shrotriya, MD, Novo Nordisk India
• Mr. Giuliano Perfetti, CEO & MD, Jubilant Biosys Limited
• Mr. Srinath Venkatesh, MD, India and South Asia, Thermo Fisher Scientific
• Mr. Amit Mookim, CEO, Immuneel Therapeutics Private Limited

Moderator: Mr. Suresh Subramanian, Partner and National Life Sciences Leader, EY India
15:05 - 15:20
Plenary Address Mr. Pushmeet Kohli, VP of Science, Google DeepMind, UK
15:25 - 16:25
Panel Discussion
Next-Gen Biologics & Advanced Modalities: From Discovery to Clinical Proof & CMC at Scale The panel will discuss how next-generation biologics and advanced modalities, including cell & gene therapies, mRNA, and radiopharmaceuticals, are progressing from discovery to clinical proof and scalable CMC, with generative AI and advanced computational tools increasingly supporting decisions across target design, process development, analytics, and manufacturing readiness.

Keynote Address: Dr. Stefan Miltenyi, Founder & President, Miltenyi Biotec, Germany

Speakers:
• Dr. Raches Ella, Chief Development Officer, Bharat Biotech
• Dr. Darrin Morrissey, CEO, NIBRT, Ireland
• Dr. Sangita Reddy, Joint MD, Apollo Hospitals Group
• Dr. José Castillo, CEO, Quantoom Biosciences, Belgium

Moderator: Mr. Gil Bashe, Chair Global Health and Purpose, FINN Partners, USA
16:30 - 17:30
Session Sponsor: BCG Panel Discussion
CRDMO 2.0: AI as a Force Multiplier Across the Value Chain As CRDMOs scale globally, they face increasing pressure to deliver faster execution, higher operational efficiency, and more personalised customer engagement. This session will explore how AI can act as a force multiplier, enhancing operational excellence, improving decision-making, and enabling strategic differentiation across the CRDMO value chain.

Speakers:
• Dr. Satyanarayana Chava, Founder and CEO, Laurus Labs
• Dr. Matthew Moorcroft, SVP, Global Marketing & Intelligence, Lonza, UK
• Mr. Manni Kantipudi, CEO, Aragen Lifesciences
• Mr. Krishna Kanumuri, MD & CEO, Sai Lifesciences

Moderator: Mr. Vikash Agarwalla, MD & Partner, BCG
17:30 - 18:00
Networking break and visit to the International Exhibition
18:00 - 19:15
Session Sponsor: Oliver Wyman CEO Conclave
Future of Pharma & Biotech (’26-’30): Growth, Headwinds & Opportunities A marquee BioAsia tradition, global CEOs in a no-holds-barred conversation about what the industry will look like by 2030. Growth, innovation, geopolitics, and resilience - all on the table.

Speakers:
• Mr. Amitabh Kant, Former G20 Sherpa, Government of India
• Mr. G. V. Prasad, Co-Chairman & MD, Dr. Reddy’s Laboratories
• Mr. Eric Mansion, GM, India & South-East Asia, Sanofi, Singapore
• Mr. Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines Limited
• Mr. Shreehas Tambe, MD and CEO, Biocon Biologics
• Dr. Toon Overstijns, CEO & Board Member, Milteyni Biotec, Belgium
• Mr. Winselow Tucker, President and GM, Lilly India

Moderator: Ms. Ekta Batra, Editor, Pharmaceuticals and Healthcare, CNBC TV18
19:15 Hrs
Networking Reception
Day 2
18th February 2026
11:00 - 11:15
Plenary Address Ms. Madeleine Roach, EVP, Head of Business Operations, Sanofi, France
11:20 - 12:20
Session Sponsor: Healthark Panel Discussion
Building Innovation-First GCCs: AI, R&D & Digital Transformation This session explores the next generation of life sciences GCCs, which are being built around intelligence, innovation, and integration. As GCCs evolve from cost centres into strategic growth engines, the panel examines how AI-enabled R&D, modern digital architectures, and new operating models are repositioning them as core contributors to global innovation strategies.

Opening Keynote: Mr. Anton Groom, Chief AI Officer, MSD, USA

Speakers:
• Mr. Badhri Srinivasan, Group CEO, Unilabs, Switzerland
• Mr. Syed Naveed, Executive Officer & CTO, Olympus Corporation, Japan
• Mr. Sanjay Patel, SVP & Global Head of Innovation Capability Solutions & Services, Takeda, Switzerland
• Mr. Som Chattopadhyay, SVP, Global Business Solutions and National Executive, Amgen, USA
• Ms. Gail Horwood, Chief Marketing and Customer Experience Officer, Novartis, USA

Moderator: Dr. Purav Gandhi, Founder & CEO, Healthark
12:25 - 13:25
Session Sponsor: KPMG Panel Discussion
Making It Matter: How GCCs Transform Capability into End-Patient Impact This session intends to showcase the impact and outcomes enabled by Healthcare GCCs on what matters: the end-patient. GCC capabilities have evolved greatly over the years, and KPMG will enable conversations with senior Healthcare leaders to understand the far-reaching impact of Healthcare GCCs. During this session, KPMG will also release a whitepaper curating key patient-impact narratives from select Healthcare GCC organisations.

Speakers:
• Ms. Siva Kumar Padmanabhan, MD & Head of Global Innovation & Technology Centre, AstraZeneca
• Ms. Chandani Palshetkar, Global Head of Strategy, Hub & Services, Opella Healthcare
• Dr. Anand Jain, Vice President, Product & Portfolio Strategy, Novo Nordisk
• Mr. Manish Arora, Associate VP & General Manager, Eli Lilly Services
• Mr. Mahesh Natarajan, Senior Director, Thermo Fisher Scientific
• Mr. Srinivas Peddi, Senior Director & Centre Head, Becton Dickinson Technology Campus

Moderator: Ms. Shalini Pillay, Partner at KPMG and India leader, GCC
13:25 - 14:25
Networking Lunch & Visit to Exhibition
14:25 - 15:25
Session Sponsor: BMS Panel Discussion
India’s Innovation Moment: Scaling the Next Phase of Global Impact India’s innovation landscape is expanding rapidly, yet challenges in funding, talent, and commercialization continue to shape the pace of progress. This session explores where India stands today, and what it will take to accelerate impact at scale.

Speakers:
• Ms. Preeti Sudan IAS (Retd.), Former Chairperson, UPSC and Former Union Health Secretary, Government of India
• Mr. Sridhar Gopal, Head of International Business Development, AbbVie, USA
• Mr. Nataraj Kalyanaraman, VP, Head of Drug Development, BMS
• Mr. Vikas Jain, VP & Head of Life Sciences, TCS
• Mr. Raja Jammalamadaka, Head, Roche Digital Centre
• Mr. Greg Killian, SVP & GM, Global Life Sciences & Healthcare, EPAM Systems, USA

Moderator: Mr. Vikas Dandekar, Editor (Pharma & Healthcare), The Economic Times
15:30 - 16:10
Panel Discussion
Financing TechBio & DeepTech Manufacturing Deep tech and advanced biotech are often seen as high-risk, but global success stories show the potential. Join this panel of leading VCs as they share what investors look for, how to de-risk innovation, and the opportunities for scaling breakthrough technologies in India for the world.

Speakers:
• Mr. Charles Janssen, Managing Partner, HealthKois, Belgium
• Mr. Karthik Narayanaswamy, Partner & Head of India, Novo Holdings
• Mr. Sunil Thakur, Partner, Quadria Capital & Co-founder, HealthQuad, Singapore
• Dr. Ramesh Byrappaneni, Managing Director, Endiya Partners
16:15 - 16:30
TELANGANA RISING 2047: BUILDING A WORLD-CLASS LIFE-SCIENCES ECOSYSTEM Fireside Chat: Sri. D. Sridhar Babu, Hon’ble Minister for Industries and Commerce, Government of Telangana
16:35 - 17:00
Valedictory and Startup Awards Ceremony